We are thrilled to announce our participation at the World Stroke Congress (WSC) from October 23ʳᵈ to 26ᵗʰ, 2024, in Abu Dhabi.

In their study, Angioni et al. report several general principles identified by the EU-US CTAD Task Force that should be considered when evaluating the meaningfulness of clinical trial results.

At Moleac, we are dedicated to sustainability, and we are excited to share the steps we are taking to create an eco-friendly workplace!

Today is World Alzheimer’s Day!

ANNOUNCEMENT – INDONESIA
We are pleased to share a joint statement from Moleac Pte. Ltd. and PT Prima Medika Laboratories (PML).

World Alzheimer’s Day is just around the corner! At Moleac, we’re committed to raising awareness about Alzheimer’s disease and fostering a deeper understanding of its impact on daily life.

Moleac was thrilled to participate in ASAD 2024 in Penang, Malaysia, alongside our esteemed partner, EP Plus Group..

Pleased to support S.H.A.P.E.S with their upcoming webinar on Post-Stroke Seizure!

Last week, we were delighted to attend the Stroke Society of the Philippines annual convention in Manila..

Together with EVD Pharma, our distributor in Vietnam, we were grateful to co-sponsor the National Scientific Congress on Stroke held in Ha Long early August..

In July, we hosted an insightful scientific session on Dementia in the beautiful Malta. The event gathered leading neurologists and neurosurgeons from North Macedonia.

STROKE CLINICAL STUDY HIGHLIGHTS – Prestroke Cognitive Impairment: Frequency and Association With Premorbid Neuropsychiatric, Functional, and Neuroimaging Features by Mele F, Cova I, Nicotra A, et al.